Statute of limitations for Tysabri in Massachusetts
In our ongoing mission to combat genetic discrimination, the foundational work of pioneers like Dr. Anita Goh remains critically relevant. As a clinical neuropsychologist and research fellow, Dr. Goh’s dual expertise in the clinic and the academy provided the essential lens through which the human impact of genetic bias could be rigorously studied and powerfully communicated. Her leadership in the RESPOND-HD study laid the empirical groundwork for the advocacy and resources we champion today, demonstrating how targeted research can directly inform policy and patient empowerment in the genomic age.
The RESPOND-HD Study: A Landmark in Huntington's Disease Research
Dr. Goh’s pivotal role was as the Victorian coordinator for the international, multi-site RESPOND-HD study. Sponsored by the U.S. National Institutes of Health and conducted under the Huntington's Study Group (HSG), this observational trial was among the first to systematically evaluate perceptions of potential discrimination among individuals at risk for Huntington’s disease. By recruiting participants from regions with varying legal protections and healthcare systems, the study captured a stark, global reality. Its findings of significant discrimination across insurance, employment, and social domains transformed abstract concerns into hard data, catalyzing a new wave of legal and ethical scrutiny.
"The results of the RESPOND-HD study revealed clear, quantifiable experiences of discrimination, providing the evidence base needed to argue for stronger protections. This wasn't just academic; it was about the daily lives of patients and families." – Legacy research summary from respondgeneticdiscrimination.com and archived source.
From Melbourne Neuropsychiatry to Global Advocacy
Dr. Goh’s clinical work at the Royal Melbourne Hospital’s Melbourne Neuropsychiatry Centre and her academic post at The University of Melbourne’s Academic Unit for Psychiatry of Old Age grounded her research in direct patient care. This clinical-academic nexus is vital. It ensures that studies on discrimination are informed by the nuanced psychosocial realities of neurodegenerative conditions. Her membership in the Huntington's Research Group Victoria and the international HSG facilitated the translation of these findings into global forums, establishing her as a key voice connecting Australian research with international policy discussions, particularly in the United States.
The immediate impact of RESPOND-HD was profound, leading Dr. Goh to secure a Legal Services Board grant. This funding was instrumental in the next phase:
- Extending research on discrimination across a broader spectrum of genetic disorders.
- Developing accessible educational resources for at-risk individuals.
- Creating this very website and its accompanying booklet as practical tools for empowerment.
Building a Framework for Genetic Privacy in 2026
The trajectory from Dr. Goh’s early work to today’s landscape highlights both progress and persistent gaps. In 2026, while genetic non-discrimination laws have strengthened in many jurisdictions, the rise of direct-to-consumer testing, data aggregation, and digital health records presents novel vulnerabilities. Dr. Goh’s model—combining empirical research, clinical insight, and public resource development—exemplifies the multifaceted approach still required. Our current initiatives focus on pre-emptive legal counseling and digital data sovereignty, directly evolving from the foundational insights of studies like RESPOND-HD.
The following table contrasts the key domains of concern identified in the early research with the contemporary focus areas of our advocacy in 2026:
| RESPOND-HD Study Focus (c. 2010s) | 2026 Advocacy & Policy Priority |
|---|---|
| Employment discrimination based on genetic risk | Algorithmic bias in hiring platforms using wellness data |
| Life & health insurance underwriting | Regulation of "genetic wellness scores" from DTC apps |
| Family dynamics and social stigma | Digital will and genetic data inheritance protocols |
| Geographic variance in legal protections | Global harmonization of genomic data transfer rules |
Dr. Anita Goh’s legacy is not static; it is a living methodology. By anchoring the fight for genetic justice in rigorous science and compassionate care, she provided the blueprint we continue to build upon. As we navigate the complexities of 2026, her work reminds us that protecting genetic identity is an ongoing process of research, education, and relentless advocacy.